• Je něco špatně v tomto záznamu ?

Noninvasive approach to mend the broken heart: Is "remote conditioning" a promising strategy for application in humans

T. Ravingerová, V. Farkašová, L. Griecsová, M. Muráriková, S. Carnická, L. Lonek, M. Ferko, J. Slezak, M. Zálešák, A. Adameova, VKM. Khandelwal, A. Lazou, F. Kolar,

. 2017 ; 95 (10) : 1204-1212. [pub] 20170706

Jazyk angličtina Země Kanada

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc18010428

Currently, there are no satisfactory interventions to protect the heart against the detrimental effects of ischemia-reperfusion injury. Although ischemic preconditioning (PC) is the most powerful form of intrinsic cardioprotection, its application in humans is limited to planned interventions, due to its short duration and technical requirements. However, many organs/tissues are capable of producing "remote" PC (RPC) when subjected to brief bouts of ischemia-reperfusion. RPC was first described in the heart where brief ischemia in one territory led to protection in other area. Later on, RPC started to be used in patients with acute myocardial infarction, albeit with ambiguous results. It is hypothesized that the connection between the signal triggered in remote organ and protection induced in the heart can be mediated by humoral and neural pathways, as well as via systemic response to short sublethal ischemia. However, although RPC has a potentially important clinical role, our understanding of the mechanistic pathways linking the local stimulus to the remote organ remains incomplete. Nevertheless, RPC appears as a cost-effective and easily performed intervention. Elucidation of protective mechanisms activated in the remote organ may have therapeutic and diagnostic implications in the management of myocardial ischemia and lead to development of pharmacological RPC mimetics.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010428
003      
CZ-PrNML
005      
20180417093654.0
007      
ta
008      
180404s2017 xxc f 000 0|eng||
009      
AR
024    7_
$a 10.1139/cjpp-2017-0200 $2 doi
035    __
$a (PubMed)28683229
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxc
100    1_
$a Ravingerová, Táňa $u a Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovakia.
245    10
$a Noninvasive approach to mend the broken heart: Is "remote conditioning" a promising strategy for application in humans / $c T. Ravingerová, V. Farkašová, L. Griecsová, M. Muráriková, S. Carnická, L. Lonek, M. Ferko, J. Slezak, M. Zálešák, A. Adameova, VKM. Khandelwal, A. Lazou, F. Kolar,
520    9_
$a Currently, there are no satisfactory interventions to protect the heart against the detrimental effects of ischemia-reperfusion injury. Although ischemic preconditioning (PC) is the most powerful form of intrinsic cardioprotection, its application in humans is limited to planned interventions, due to its short duration and technical requirements. However, many organs/tissues are capable of producing "remote" PC (RPC) when subjected to brief bouts of ischemia-reperfusion. RPC was first described in the heart where brief ischemia in one territory led to protection in other area. Later on, RPC started to be used in patients with acute myocardial infarction, albeit with ambiguous results. It is hypothesized that the connection between the signal triggered in remote organ and protection induced in the heart can be mediated by humoral and neural pathways, as well as via systemic response to short sublethal ischemia. However, although RPC has a potentially important clinical role, our understanding of the mechanistic pathways linking the local stimulus to the remote organ remains incomplete. Nevertheless, RPC appears as a cost-effective and easily performed intervention. Elucidation of protective mechanisms activated in the remote organ may have therapeutic and diagnostic implications in the management of myocardial ischemia and lead to development of pharmacological RPC mimetics.
650    _2
$a zvířata $7 D000818
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a lidé $7 D006801
650    _2
$a ischemické přivykání $x metody $7 D019157
650    _2
$a infarkt myokardu $x metabolismus $x patologie $x patofyziologie $x prevence a kontrola $7 D009203
650    _2
$a reperfuzní poškození myokardu $x metabolismus $x patologie $x patofyziologie $x prevence a kontrola $7 D015428
650    _2
$a myokard $x metabolismus $x patologie $7 D009206
650    _2
$a regionální krevní průtok $7 D012039
650    _2
$a signální transdukce $7 D015398
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Farkašová, Veronika $u a Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Griecsová, Lucia $u a Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Muráriková, Martina $u a Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Carnická, Slavka $u a Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Lonek, L'ubomír $u a Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Ferko, Miroslav $u a Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Slezak, Jan $u a Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Zálešák, Marek $u a Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Adameova, Adriana $u b Faculty of Pharmacy, Comenius University, Bratislava, Slovakia.
700    1_
$a Khandelwal, Vinoth K M $u c Venus Medicine Research Centre, Hill Top Industrial Estate, Baddi, India.
700    1_
$a Lazou, Antigone $u d School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
700    1_
$a Kolar, Frantisek $u e Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
773    0_
$w MED00001020 $t Canadian journal of physiology and pharmacology $x 1205-7541 $g Roč. 95, č. 10 (2017), s. 1204-1212
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28683229 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180417093752 $b ABA008
999    __
$a ok $b bmc $g 1287913 $s 1007240
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 95 $c 10 $d 1204-1212 $e 20170706 $i 1205-7541 $m Canadian journal of physiology and pharmacology $n Can J Physiol Pharmacol $x MED00001020
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Možnosti archivace